The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels
Open Access
- 1 August 1998
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (3) , 413-418
- https://doi.org/10.1038/bjc.1998.508
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled studyUrology, 1995
- Three-year safety and efficacy data on the use of finasteride in the treatment of benign prostatic hyperplasiaUrology, 1994
- The influence of finasteride on the volume of the peripheral and periurethral zones of the prostate in men with benign prostatic hyperplasiaThe Prostate, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black malesThe Lancet, 1992
- Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.Journal of Histochemistry & Cytochemistry, 1991
- Effect of castration, DES, flutamide, and the 5α-reductase inhibitor, MK-906, on the growth of the dunning rat prostatic carcinoma, R-3327The Prostate, 1991
- Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasmsThe Journal of Pathology, 1990
- Steroid 5α-Reductase Deficiency in Man: An Inherited Form of Male PseudohermaphroditismScience, 1974